Cargando…
A prognostic estimation model based on mRNA-sequence data for patients with oligodendroglioma
BACKGROUND: The diagnosis of oligodendroglioma based on the latest World Health Organization Classification of Tumors of the Central Nervous System (WHO CNS 5) criteria requires the codeletion of chromosome arms 1p and 19q and isocitrate dehydrogenase gene (IDH) mutation (mut). Previously identified...
Autores principales: | Zhu, Qinghui, Shen, Shaoping, Yang, Chuanwei, Li, Mingxiao, Zhang, Xiaokang, Li, Haoyi, Zhao, Xuzhe, Li, Ming, Cui, Yong, Ren, Xiaohui, Lin, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795846/ https://www.ncbi.nlm.nih.gov/pubmed/36588901 http://dx.doi.org/10.3389/fneur.2022.1074593 |
Ejemplares similares
-
Orelabrutinib Combined With Lenalidomide and Immunochemotherapy for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Retrospective Analysis of Case Series
por: Yang, Chuanwei, et al.
Publicado: (2022) -
T2/FLAIR Abnormity Could be the Sign of Glioblastoma Dissemination
por: Li, Mingxiao, et al.
Publicado: (2022) -
Nomograms for predicting cancer-specific survival in patients with primary central nervous system lymphoma: a population-based analysis
por: Yang, Chuanwei, et al.
Publicado: (2021) -
Combination of Immunotherapy and Radiotherapy for Recurrent Malignant Gliomas: Results From a Prospective Study
por: Jiang, Haihui, et al.
Publicado: (2021) -
Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant Glioblastoma
por: Jiang, Haihui, et al.
Publicado: (2021)